← Open Payments lookup

KATHERINE COLLINS: Open Payments

NPI 1548802523 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,519 in 113 payments from 34 companies in 2025. Trend: 2023 $1,556 · 2024 $1,043 · 2025 $2,519

Food & beverage: $2,324Education: $195
CompanyPaymentsAmount
Janssen Biotech, Inc.15$352
ABBVIE INC.13$303
Merck Sharp & Dohme LLC14$245
PFIZER INC.7$131
GlaxoSmithKline, LLC.5$109
Myriad Genetic Laboratories, Inc.1$105
Incyte Corporation6$103
Novartis Pharmaceuticals Corporation5$102
SEAGEN INC.1$99
Takeda Pharmaceuticals U.S.A., Inc.3$88

Products named: KEYTRUDA, RYBREVANT, VENCLEXTA, ERLEADA, MYRISK, CARVYKTI, IMBRUVICA, EPKINLY.

Industry payments across MO — which companies pay providers there.